A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657. (Q44271037)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657. |
scientific article |
Statements
1 reference
A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657. (English)
1 reference
Michelle M Le Beau
1 reference
Jastinder Sohal
1 reference
Vernon T Phan
1 reference
Philip V Chan
1 reference
Elizabeth M Davis
1 reference
Bhumi Patel
1 reference
Louise M Kelly
1 reference
Tinya J Abrams
1 reference
Anne Marie O'Farrell
1 reference
D Gary Gilliland
1 reference
Scott C Kogan
1 reference
19 December 2002
1 reference
1 reference
Identifiers
1 reference